-
381
INVESTIGATING THE ROLE OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE-1 (ERAP1) IN ANKYLOSING SPONDYLITIS
Published 2010Journal article -
382
INVESTIGATING THE ROLE OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE-1 (ERAP1) IN ANKYLOSING SPONDYLITIS
Published 2010Journal article -
383
Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis.
Published 2013“…In the meantime the modified New York criteria for ankylosing spondylitis remain a very useful classification criteria set, defining a relatively homogenous group of cases for clinical use and research studies.…”
Journal article -
384
Axial spondyloarthritis: A new disease entity, not necessarily early ankylosing spondylitis
Published 2013“…In the meantime the modified New York criteria for ankylosing spondylitis remain a very useful classification criteria set, defining a relatively homogenous group of cases for clinical use and research studies.…”
Journal article -
385
Collagen-specific cytotoxic T lymphocyte responses in patients with ankylosing spondylitis and reactive arthritis.
Published 1994“…Both ankylosing spondylitis (AS) and reactive arthritis (ReA) are strongly associated with HLA-B27 although the mechanism for this association is still unknown. …”
Journal article -
386
IMPACT OF ANKLOSING SPONDYLITIS-ASSOCIATED ERAP1 VARIANTS ON ITS AMINOPEPTIDASE ACTIVITY
Published 2010Journal article -
387
Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese.
Published 2011“… OBJECTIVES: Recent association studies by the Australo-Anglo-American Spondyloarthritis Consortium (TASC) in Caucasian European populations from Australia, North America and the UK have identified a number of genes as being associated with ankylosing spondylitis (AS). A candidate gene study in a Han Chinese population was performed based on these findings to identify associated genes in this population. …”
Journal article -
388
The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis.
Published 2004“…A structured questionnaire was used to assess the age of symptom onset, disease duration and disease severity scores, including the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) and BASFI (Bath Ankylosing Spondylitis Functional Index). …”
Journal article -
389
A double-blind cross-over trial of fenoprofen and phenylbutazone in ankylosing spondylitis.
Published 1980“…Fenoprofen, 600 mg, three times daily, was compared with phenylbutazone, 100 mg, three times daily, in 30 patients suffering from ankylosing spondylitis in a double-blind cross-over study. Assessments were made after an initial washout period and after each month-long treatment period. …”
Journal article -
390
Evidence for a second ankylosing spondylitis-associated RUNX3 regulatory polymorphism
Published 2018“…To explore the functions of RUNX3 single nucleotide polymorphisms (SNPs) associated with ankylosing spondylitis (AS).Individual SNP associations were evaluated in 4230 UK cases. …”
Journal article -
391
Diagnostic capacity of genetic tests in Ankylosing spondylitis can exceed MRI scanning
Published 2008Conference item -
392
A proteomic approach to the identification of marker proteins for ankylosing spondylitis and rheumatoid arthritis
Published 2005Journal article -
393
IMPACT OF ANKYLOSING SPONDYLITIS-ASSOCIATED ERAP1 VARIANTS ON ITS AMINOPEPTIDASE ACTIVITY
Published 2010Journal article -
394
Disease severity in Ankylosing Spondylitis: The influence of associated inflammatory bowel disease and psoriasis
Published 2008Journal article -
395
Functional genomic analysis of a RUNX3 polymorphism associated with ankylosing spondylitis
Published 2021“…Objective To investigate the functional consequences of the single-nucleotide polymorphism rs4648889 in a putative enhancer upstream of the RUNX3 promoter associated with susceptibility to ankylosing spondylitis (AS). Methods Using nuclear extracts from Jurkat cells and primary human CD8+ T cells, the effects of rs4648889 on allele-specific transcription factor (TF) binding were investigated by DNA pull-down assay and quantitative mass spectrometry (qMS), with validation by electrophoretic mobility shift assay (EMSA), Western blotting of the pulled-down eluates, and chromatin immunoprecipitation (ChIP)–quantitative polymerase chain reaction (qPCR) analysis. …”
Journal article -
396
EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS
Published 2012Conference item -
397
Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis.
Published 2000“…Ankylosing spondylitis (AS) is a common and highly familial rheumatic disorder. …”
Journal article -
398
Axial spondyloarthritis: A new disease entity, not necessarily early ankylosing spondylitis
Published 2012Journal article -
399
Ankylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2).
Published 2014“…OBJECTIVES: ANTXR2 variants have been associated with ankylosing spondylitis (AS) in two previous genome-wide association studies (GWAS) (p∼9×10(-8)). …”
Journal article -
400
HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.
Published 1996“…OBJECTIVE: To investigate the HLA class I associations of ankylosing spondylitis (AS) in the white population, with particular reference to HLA-B27 subtypes. …”
Journal article